Skip to content

MDS GmbH 2

Active Risk: not assessed
Foreign entityfounded 1999active for 27 yearsAm Winkelgraben 13, Biebesheim 64584, GermanyKBO/BCE: BE 0466.866.839

From the official registers: KBO publications in the Belgian Official Gazette

Summary

MDS GmbH 2 has the legal form “Foreign entity” in the KBO; Checked does not compute a bankruptcy probability for it. The company has been active since 1999 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 1 administrative register entry (see administrative flags). No annual accounts have been filed with the National Bank.

Overview

Official details

KBO
Status
Active since 01-09-1999 Normal situation
Legal form
Foreign entity
Registered office
Am Winkelgraben 13, Biebesheim 64584, Germany
Activity
No activity registered in the KBO
Establishment unit
2.094.894.053 since 01-03-2000
Peppol
Not found in the Peppol Directory

How it is doing

No score: no figuresBankruptcy probability: legal form outside the model
No accounts filed yet
Signalsraises riskAdministrative warnings in the KBO publicationsShow the evidence

Signals

1 signal.
raises risk
raises risk · Administrative warnings in the KBO publications
1 publication by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or its withdrawal.
KBO publications
Publications
Branch address struck

Documents

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about MDS GmbH 2

What is the company number of MDS GmbH 2?
0466.866.839. In Belgium the VAT number is the company number with BE in front: BE 0466.866.839.
Where is MDS GmbH 2 based?
The registered office is at Am Winkelgraben 13, Biebesheim 64584.Company details
What is the legal form of MDS GmbH 2?
Foreign entity.
When was MDS GmbH 2 founded?
On 01-09-1999.
Is MDS GmbH 2 still active?
Yes, MDS GmbH 2 is an active enterprise in the KBO register.

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.